Treatment of African children with uncomplicated falciparum malaria with a new antimalarial drug, CGP 56697

Journal of Infectious Diseases

Volumn 176, Issue 4, 1997, Pages 1113-1116

  Von Seidlein, Lorenz ^a   Jaffar, Shabbar ^b   Pinder, Margaret ^b   Haywood, Michelle ^b   Snounou, Georges ^b   Gemperli, Beatrice ^b   Gathmann, Insa ^b   Royce, Catherine ^b   Greenwood, Brian ^b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ANTIMALARIAL AGENT; ARTEMETHER; ARTEMETHER PLUS BENFLUMETOL; ASPARTATE AMINOTRANSFERASE; BENFLUMETOL; BILIRUBIN; POTASSIUM; PROTOZOAL DNA; SODIUM; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; GAMBIA; GIEMSA STAIN; HUMAN; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; ORAL DRUG ADMINISTRATION; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; QT INTERVAL; TABLET;

EID: 0030812746     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/516524     Document Type: Article

References (14)

1. Klayman DL. Qinghaosu (artemisinin): an antimalarial drug from China. Science 1985;228:1049-55.
2. Meshnick SR, Taylor TE, Kamchonwongpaisan S. Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy. Microbiol Rev 1996;60:301-15.
3. White N. Artemisinin: current status. Trans R Soc Trop Med Hyg 1994; 88:3-4.
4. Institute of Microbiology and Epidemiology. Benfiumetol registration dossier. Beijing: IME, Academy of Military Medical Sciences, 1993.
5. Viriyakosol S, Siripoon N, Petcharapirat C, et al. Genotyping of Plasmodium falciparum isolates by the polymerase chain reaction and potential uses in epidemiologic studies. Bull World Health Organ 1995;73:85-95.
6. Brewer TG, Grate SJ, Peggins JO, et al. Fatal neurotoxicity of arteether and artemether. Am J Trop Med Hyg 1994; 51:251-9.
7. Boele van Hensbroek M, Onyiorah E, Jaffar S, et al. A trial of artemether or quinine in children with cerebral malaria. N Eng J Med 1996;335: 69-75.
8. C interval in African children treated for falciparum malaria. Am J Trop Med Hyg 1997;56:494-7.
9. Mueller O, Boele van Hensbroek M, Jaffar S, et al. A randomized trial of chloroquine, amiodiaquine and pyrimethamine-sulphadoxine in Gambian children with uncomplicated malaria. Trop Med Int Health 1996; 1:124-32.
10. Kumar N, Zheng H. Stage specific gametocytocidal effect in vitro of the antimalarial drug quinghaosu on Plasmodium falciparum. Parasitol Res 1990;76:214-8.
11. Dutta GP, Mohan A, Tripathi R. Study of the gametocidal/sporontocidal action of quinghaosu by electron microscopy. J Parasitol 1990;76:849-52.
12. Price RN, Nosten F, Luxemburger C, et al. Effects of artemisinin derivatives on malaria transmissibility. Lancet 1996;347:1654-8.
13. Kain KC, Craig AA, Ohrt C. Single-strand conformational polymorphism analysis differentiates Plasmodium falciparum treatment failures from reinfections. Mol Biochem Parasitol 1996;79:167-75.
14. Lindsay S, Campbell H, Adiamah J, Greenwood A, Bangali J, Greenwood B. Malaria in a periurban area of The Gambia. Ann Trop Med Parasitol 1990;84:553-622.